The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
110796732 11079673 2 F 20110615 20160908 20150430 20160920 EXP US-TEVA-558347USA TEVA 70.00 YR F Y 53.12000 KG 20160920 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
110796732 11079673 1 PS METFORMIN METFORMIN HYDROCHLORIDE 1 Oral 1500 MILLIGRAM DAILY; Y 75975 500 MG TID
110796732 11079673 2 SS FOSAMAX ALENDRONATE SODIUM 1 Oral Y 0 35 MG /wk
110796732 11079673 3 SS IBUPROFEN. IBUPROFEN 1 Oral 600 MILLIGRAM DAILY; Y 70435 200 MG TID
110796732 11079673 4 SS IBUPROFEN. IBUPROFEN 1 Oral 600 MILLIGRAM DAILY; Y 70435 200 MG TID
110796732 11079673 5 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral 80 MILLIGRAM DAILY; 0 80 MG QD
110796732 11079673 6 C NORVASC AMLODIPINE BESYLATE 1 Oral 5 MILLIGRAM DAILY; 0 5 MG QD
110796732 11079673 7 C SIMVASTATIN. SIMVASTATIN 1 Oral 40 MILLIGRAM DAILY; 0 40 MG QD
110796732 11079673 8 C BENICAR OLMESARTAN MEDOXOMIL 1 Oral 20 MILLIGRAM DAILY; 0 20 MG QD
110796732 11079673 9 C CINNAMON. CINNAMON 1 Oral 500 MILLIGRAM DAILY; 0 500 MG QD
110796732 11079673 10 C VITAMIN D3 CHOLECALCIFEROL 1 Oral 2000 MILLIGRAM DAILY; 0 2000 MG QD
110796732 11079673 11 C CALCIUM CALCIUM 1 Oral 1200 MILLIGRAM DAILY; 0 600 MG BID
110796732 11079673 12 C OMEGA 3 OMEGA-3 FATTY ACIDS 1 Oral 600 MILLIGRAM DAILY; 0 300 MG BID
110796732 11079673 13 C FIBERMED 2 Oral 4 DOSAGE FORMS DAILY; 0 2 DF CAPSULE BID
110796732 11079673 14 C MULTIVITAMINS VITAMINS 1 Oral 1 DOSAGE FORMS DAILY; 0 1 DF TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
110796732 11079673 1 Diabetes mellitus
110796732 11079673 2 Osteopenia
110796732 11079673 3 Osteoarthritis
110796732 11079673 4 Rheumatoid arthritis
110796732 11079673 5 Gastrooesophageal reflux prophylaxis
110796732 11079673 6 Hypertension
110796732 11079673 7 Dyslipidaemia
110796732 11079673 8 Hypertension
110796732 11079673 9 Routine health maintenance
110796732 11079673 10 Routine health maintenance
110796732 11079673 11 Routine health maintenance
110796732 11079673 12 Routine health maintenance
110796732 11079673 13 Routine health maintenance
110796732 11079673 14 Routine health maintenance

Outcome of event

Event ID CASEID OUTC COD
110796732 11079673 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
110796732 11079673 Condition aggravated
110796732 11079673 Gastrooesophageal reflux disease

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
110796732 11079673 1 20110509 20110706 0
110796732 11079673 2 201010 20110729 0
110796732 11079673 3 20101130 20110708 0
110796732 11079673 4 20140528 0
110796732 11079673 5 20101130 20120405 0
110796732 11079673 6 2007 0
110796732 11079673 7 201008 0
110796732 11079673 8 2008 0
110796732 11079673 9 2008 0
110796732 11079673 10 201005 0
110796732 11079673 11 2000 0
110796732 11079673 12 2009 0
110796732 11079673 13 200605 0
110796732 11079673 14 1995 0